Infectious Disease Reports
Volume 12, March 2020, Issue 1, 8543
Nicastri, E.; Petrosillo, N.; Bartoli, T. A.; Lepore, L.; Mondi, A.; Palmieri, F.; D'Offizi, G.; Marchioni, L.; Murachelli, S.; Ippolito, G.; Antinori, A.
Abstract
On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The "L. Spallanzani" National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data.
Keywords
COVID-19, SARS-CoV-2, Treatment